 | • レポートコード：MRC2-11QY04564 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は季節性情動障害のグローバル市場について調査・分析したレポートです。種類別（光線療法、医薬品、その他）市場規模、用途別（病院、診療所、家庭用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別季節性情動障害の競争状況、市場シェア ・世界の季節性情動障害市場：種類別市場規模 2015年-2020年（光線療法、医薬品、その他） ・世界の季節性情動障害市場：種類別市場規模予測 2021年-2026年（光線療法、医薬品、その他） ・世界の季節性情動障害市場：用途別市場規模 2015年-2020年（病院、診療所、家庭用、その他） ・世界の季節性情動障害市場：用途別市場規模予測 2021年-2026年（病院、診療所、家庭用、その他） ・北米の季節性情動障害市場分析：米国、カナダ ・ヨーロッパの季節性情動障害市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの季節性情動障害市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の季節性情動障害市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの季節性情動障害市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc. (US)、Allergan (Republic of Ireland)、Bayer AG (Germany)、Bristol-Myers Squibb Company (US)、F. Hoffmann-La Roche Ltd. (Switzerland)、Henry Schein(US)、Pfizer Inc. (US) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Seasonal Affective Disorder (SAD) is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between the ages of 15 to 55, and the people who live far from the equator where winter daylight hours are too short. Some major symptoms of this disorder are hopelessness, increased appetite, weight gain, loss of the ability to concentrate, social withdrawal etc. There are some risk factors associated with this disorder such as major depressive disorder, Bipolar I disorder, Bipolar II disorder, and others.
The Americas hold the largest share in the global Seasonal affective disorder market. North America dominates the market in this region. Approximately 5% of the US population is suffering from seasonal depression Some other factors such as changing lifestyle plays an important role in market growth. South America market is also growing significantly, especially growth is higher in countries such as Brazil due to increasing awareness about various mental disorders.
Market Analysis and Insights: Global Seasonal Affective Disorder Market
The global Seasonal Affective Disorder market size is projected to reach US$ 544.7 million by 2026, from US$ 531 million in 2020, at a CAGR of 2.4%% during 2021-2026.
Global Seasonal Affective Disorder Scope and Market Size
Seasonal Affective Disorder market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie Inc. (US)
Allergan (Republic of Ireland)
Bayer AG (Germany)
Bristol-Myers Squibb Company (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Henry Schein(US)
Pfizer Inc. (US)
…
Market segment by Type, the product can be split into
Light Therapy
Medications
Others
Market segment by Application, split into
Hospital
Clinic
Household
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Seasonal Affective Disorder Revenue
1.4 Market by Type
1.4.1 Global Seasonal Affective Disorder Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Light Therapy
1.4.3 Medications
1.4.4 Others
1.5 Market by Application
1.5.1 Global Seasonal Affective Disorder Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Seasonal Affective Disorder Market Perspective (2015-2026)
2.2 Global Seasonal Affective Disorder Growth Trends by Regions
2.2.1 Seasonal Affective Disorder Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Seasonal Affective Disorder Historic Market Share by Regions (2015-2020)
2.2.3 Seasonal Affective Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Seasonal Affective Disorder Market Growth Strategy
2.3.6 Primary Interviews with Key Seasonal Affective Disorder Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Seasonal Affective Disorder Players by Market Size
3.1.1 Global Top Seasonal Affective Disorder Players by Revenue (2015-2020)
3.1.2 Global Seasonal Affective Disorder Revenue Market Share by Players (2015-2020)
3.1.3 Global Seasonal Affective Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Seasonal Affective Disorder Market Concentration Ratio
3.2.1 Global Seasonal Affective Disorder Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Seasonal Affective Disorder Revenue in 2019
3.3 Seasonal Affective Disorder Key Players Head office and Area Served
3.4 Key Players Seasonal Affective Disorder Product Solution and Service
3.5 Date of Enter into Seasonal Affective Disorder Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Seasonal Affective Disorder Historic Market Size by Type (2015-2020)
4.2 Global Seasonal Affective Disorder Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Seasonal Affective Disorder Market Size by Application (2015-2020)
5.2 Global Seasonal Affective Disorder Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Seasonal Affective Disorder Market Size (2015-2020)
6.2 Seasonal Affective Disorder Key Players in North America (2019-2020)
6.3 North America Seasonal Affective Disorder Market Size by Type (2015-2020)
6.4 North America Seasonal Affective Disorder Market Size by Application (2015-2020)
7 Europe
7.1 Europe Seasonal Affective Disorder Market Size (2015-2020)
7.2 Seasonal Affective Disorder Key Players in Europe (2019-2020)
7.3 Europe Seasonal Affective Disorder Market Size by Type (2015-2020)
7.4 Europe Seasonal Affective Disorder Market Size by Application (2015-2020)
8 China
8.1 China Seasonal Affective Disorder Market Size (2015-2020)
8.2 Seasonal Affective Disorder Key Players in China (2019-2020)
8.3 China Seasonal Affective Disorder Market Size by Type (2015-2020)
8.4 China Seasonal Affective Disorder Market Size by Application (2015-2020)
9 Japan
9.1 Japan Seasonal Affective Disorder Market Size (2015-2020)
9.2 Seasonal Affective Disorder Key Players in Japan (2019-2020)
9.3 Japan Seasonal Affective Disorder Market Size by Type (2015-2020)
9.4 Japan Seasonal Affective Disorder Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Seasonal Affective Disorder Market Size (2015-2020)
10.2 Seasonal Affective Disorder Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Seasonal Affective Disorder Market Size by Type (2015-2020)
10.4 Southeast Asia Seasonal Affective Disorder Market Size by Application (2015-2020)
11 India
11.1 India Seasonal Affective Disorder Market Size (2015-2020)
11.2 Seasonal Affective Disorder Key Players in India (2019-2020)
11.3 India Seasonal Affective Disorder Market Size by Type (2015-2020)
11.4 India Seasonal Affective Disorder Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Seasonal Affective Disorder Market Size (2015-2020)
12.2 Seasonal Affective Disorder Key Players in Central & South America (2019-2020)
12.3 Central & South America Seasonal Affective Disorder Market Size by Type (2015-2020)
12.4 Central & South America Seasonal Affective Disorder Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie Inc. (US)
13.1.1 AbbVie Inc. (US) Company Details
13.1.2 AbbVie Inc. (US) Business Overview
13.1.3 AbbVie Inc. (US) Seasonal Affective Disorder Introduction
13.1.4 AbbVie Inc. (US) Revenue in Seasonal Affective Disorder Business (2015-2020))
13.1.5 AbbVie Inc. (US) Recent Development
13.2 Allergan (Republic of Ireland)
13.2.1 Allergan (Republic of Ireland) Company Details
13.2.2 Allergan (Republic of Ireland) Business Overview
13.2.3 Allergan (Republic of Ireland) Seasonal Affective Disorder Introduction
13.2.4 Allergan (Republic of Ireland) Revenue in Seasonal Affective Disorder Business (2015-2020)
13.2.5 Allergan (Republic of Ireland) Recent Development
13.3 Bayer AG (Germany)
13.3.1 Bayer AG (Germany) Company Details
13.3.2 Bayer AG (Germany) Business Overview
13.3.3 Bayer AG (Germany) Seasonal Affective Disorder Introduction
13.3.4 Bayer AG (Germany) Revenue in Seasonal Affective Disorder Business (2015-2020)
13.3.5 Bayer AG (Germany) Recent Development
13.4 Bristol-Myers Squibb Company (US)
13.4.1 Bristol-Myers Squibb Company (US) Company Details
13.4.2 Bristol-Myers Squibb Company (US) Business Overview
13.4.3 Bristol-Myers Squibb Company (US) Seasonal Affective Disorder Introduction
13.4.4 Bristol-Myers Squibb Company (US) Revenue in Seasonal Affective Disorder Business (2015-2020)
13.4.5 Bristol-Myers Squibb Company (US) Recent Development
13.5 F. Hoffmann-La Roche Ltd. (Switzerland)
13.5.1 F. Hoffmann-La Roche Ltd. (Switzerland) Company Details
13.5.2 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
13.5.3 F. Hoffmann-La Roche Ltd. (Switzerland) Seasonal Affective Disorder Introduction
13.5.4 F. Hoffmann-La Roche Ltd. (Switzerland) Revenue in Seasonal Affective Disorder Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
13.6 Henry Schein(US)
13.6.1 Henry Schein(US) Company Details
13.6.2 Henry Schein(US) Business Overview
13.6.3 Henry Schein(US) Seasonal Affective Disorder Introduction
13.6.4 Henry Schein(US) Revenue in Seasonal Affective Disorder Business (2015-2020)
13.6.5 Henry Schein(US) Recent Development
13.7 Pfizer Inc. (US)
13.7.1 Pfizer Inc. (US) Company Details
13.7.2 Pfizer Inc. (US) Business Overview
13.7.3 Pfizer Inc. (US) Seasonal Affective Disorder Introduction
13.7.4 Pfizer Inc. (US) Revenue in Seasonal Affective Disorder Business (2015-2020)
13.7.5 Pfizer Inc. (US) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Seasonal Affective Disorder Key Market Segments
Table 2. Key Players Covered: Ranking by Seasonal Affective Disorder Revenue
Table 3. Ranking of Global Top Seasonal Affective Disorder Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Seasonal Affective Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Light Therapy
Table 6. Key Players of Medications
Table 7. Key Players of Others
Table 8. Global Seasonal Affective Disorder Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Seasonal Affective Disorder Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Seasonal Affective Disorder Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Seasonal Affective Disorder Market Share by Regions (2015-2020)
Table 12. Global Seasonal Affective Disorder Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Seasonal Affective Disorder Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Seasonal Affective Disorder Market Growth Strategy
Table 18. Main Points Interviewed from Key Seasonal Affective Disorder Players
Table 19. Global Seasonal Affective Disorder Revenue by Players (2015-2020) (Million US$)
Table 20. Global Seasonal Affective Disorder Market Share by Players (2015-2020)
Table 21. Global Top Seasonal Affective Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder as of 2019)
Table 22. Global Seasonal Affective Disorder by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Seasonal Affective Disorder Product Solution and Service
Table 25. Date of Enter into Seasonal Affective Disorder Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 28. Global Seasonal Affective Disorder Market Size Share by Type (2015-2020)
Table 29. Global Seasonal Affective Disorder Revenue Market Share by Type (2021-2026)
Table 30. Global Seasonal Affective Disorder Market Size Share by Application (2015-2020)
Table 31. Global Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 32. Global Seasonal Affective Disorder Market Size Share by Application (2021-2026)
Table 33. North America Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 35. North America Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 36. North America Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 37. North America Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 38. North America Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 39. Europe Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 41. Europe Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 43. Europe Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 45. China Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 46. China Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 47. China Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 48. China Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 49. China Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 50. China Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 51. Japan Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 53. Japan Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 55. Japan Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 59. Southeast Asia Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 61. Southeast Asia Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 63. India Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 64. India Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 65. India Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 66. India Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 67. India Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 68. India Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Seasonal Affective Disorder Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Seasonal Affective Disorder Market Share (2019-2020)
Table 71. Central & South America Seasonal Affective Disorder Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Seasonal Affective Disorder Market Share by Type (2015-2020)
Table 73. Central & South America Seasonal Affective Disorder Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Seasonal Affective Disorder Market Share by Application (2015-2020)
Table 75. AbbVie Inc. (US) Company Details
Table 76. AbbVie Inc. (US) Business Overview
Table 77. AbbVie Inc. (US) Product
Table 78. AbbVie Inc. (US) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 79. AbbVie Inc. (US) Recent Development
Table 80. Allergan (Republic of Ireland) Company Details
Table 81. Allergan (Republic of Ireland) Business Overview
Table 82. Allergan (Republic of Ireland) Product
Table 83. Allergan (Republic of Ireland) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 84. Allergan (Republic of Ireland) Recent Development
Table 85. Bayer AG (Germany) Company Details
Table 86. Bayer AG (Germany) Business Overview
Table 87. Bayer AG (Germany) Product
Table 88. Bayer AG (Germany) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 89. Bayer AG (Germany) Recent Development
Table 90. Bristol-Myers Squibb Company (US) Company Details
Table 91. Bristol-Myers Squibb Company (US) Business Overview
Table 92. Bristol-Myers Squibb Company (US) Product
Table 93. Bristol-Myers Squibb Company (US) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 94. Bristol-Myers Squibb Company (US) Recent Development
Table 95. F. Hoffmann-La Roche Ltd. (Switzerland) Company Details
Table 96. F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview
Table 97. F. Hoffmann-La Roche Ltd. (Switzerland) Product
Table 98. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 99. F. Hoffmann-La Roche Ltd. (Switzerland) Recent Development
Table 100. Henry Schein(US) Company Details
Table 101. Henry Schein(US) Business Overview
Table 102. Henry Schein(US) Product
Table 103. Henry Schein(US) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 104. Henry Schein(US) Recent Development
Table 105. Pfizer Inc. (US) Company Details
Table 106. Pfizer Inc. (US) Business Overview
Table 107. Pfizer Inc. (US) Product
Table 108. Pfizer Inc. (US) Revenue in Seasonal Affective Disorder Business (2015-2020) (Million US$)
Table 109. Pfizer Inc. (US) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Seasonal Affective Disorder Market Share by Type: 2020 VS 2026
Figure 2. Light Therapy Features
Figure 3. Medications Features
Figure 4. Others Features
Figure 5. Global Seasonal Affective Disorder Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Household Case Studies
Figure 9. Other Case Studies
Figure 10. Seasonal Affective Disorder Report Years Considered
Figure 11. Global Seasonal Affective Disorder Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Seasonal Affective Disorder Market Share by Regions: 2020 VS 2026
Figure 13. Global Seasonal Affective Disorder Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Seasonal Affective Disorder Market Share by Players in 2019
Figure 16. Global Top Seasonal Affective Disorder Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Seasonal Affective Disorder Revenue in 2019
Figure 18. North America Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Seasonal Affective Disorder Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
季節性情動障害治療の世界市場（～2026年） Seasonal Affective Disorder is a type of depression that occurs during a certain time of the year. This disorder is related to changes in seasons, mostly occurs in winter but some people may have this disorder in summers as well. Seasonal affective disorder is most common in women, people between th…- うつ病治療療法の世界市場（～2026年） Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and growing strength of generic drug manufacturers. The introduction of virtual reality in the …
- 心的外傷後ストレス障害（PTSD）治療薬の世界市場（～2026年） Post-Traumatic Stress Disorder (PTSD) therapeutics include drugs that are used in the treatment of PTSD. The rising prevalence of PTSD to be one of the primary growth factors for the post-traumatic stress disorder (PTSD) therapeutics market. Market Analysis and Insights: Global Post-Traumatic Stress…
- 強迫性障害治療の世界市場（～2026年） Market Analysis and Insights: Global Obsessive-Compulsive Disorder Treatment Market The global Obsessive-Compulsive Disorder Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Obsessive-Compulsive Disorder Treat…
- 睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …